To print: Select File and then Print from your browser's menu

Title: Risk Scores Predict Stroke and Mortality Among Patients with New Onset Atrial Fibrillation

URL:

JAMA 2003;290:1049-1056.
08/26/2003 04:32:41 PM
By Joene Hendry

The risk of stroke alone or stroke and death over a 5-year period among individuals with new onset atrial fibrillation can be estimated with a set of risk scores established using findings from the Framingham Heart Study. "An understanding of absolute risk is fundamental to many clinical decisions involving patients with atrial fibrillation," writes Emelia J. Benjamin, MD, ScM, and colleagues with the Framingham Heart Study, Massachusetts, United States. Among a prospective, community-based, observational cohort living in Framingham, the researchers used Cox proportional hazards models to assess predictors for developing stroke (either ischaemic or hemorrhagic) and stroke or death by censoring the initiation of warfarin treatment during follow up. Of the overall 868 patients with new onset atrial fibrillation, 705 did not receive warfarin at baseline. After censoring for warfarin use during a mean follow up of 4.0 years the researchers found that 83 stroke and 382 stroke or death events occurred. Risk predictors for stroke, including advancing age, female sex, increasing systolic blood pressure, diabetes, and prior transient ischaemic attack or stroke, were used to derive a risk score for stroke. These scores, when added together, can estimate the 5-year risk of stroke based on the individualised data of each patient with new onset atrial fibrillation. "With the risk score," Dr. Benjamin and colleagues write, "14.3% of the cohort had a predicted 5-year stroke rate less than or equal to 7.5% and 30.6% of the cohort had a predicted 5-year stroke rate of less than or equal 10%." Similar predictors, with the addition of prior congestive heart failure or myocardial infarction, smoking, significant heart murmur, and electrocardiographic left ventricular hypertrophy, were used to derive a risk score for stroke or death. The investigators note that the risk associated with atrial fibrillation is highly variable. "These risk scores can be used to estimate the absolute risk of an adverse event in individuals diagnosed with atrial fibrillation," the authors write, "which may be helpful in counselling patients and in making treatment decisions." Dr. Benjamin and colleagues conclude however, "because several risk schemes for atrial fibrillation now exist, it will be critical to validate this risk prediction instrument in an independent cohort and to assess its performance relative to other risk schemes."

Copyright © 2009 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content.